Tremblay G, Majethia U, Breeze JL, Kontoudis I, & Park J. (2016). Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea. Dove Medical Press.
Chicago Style (17th ed.) CitationTremblay G, Majethia U, Breeze JL, Kontoudis I, and Park J. Economic Evaluation of Eribulin as Second-line Treatment for Metastatic Breast Cancer in South Korea. Dove Medical Press, 2016.
MLA (9th ed.) CitationTremblay G, et al. Economic Evaluation of Eribulin as Second-line Treatment for Metastatic Breast Cancer in South Korea. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.